FDA Issues Warning About Rare and Serious Reaction to Antiseizure Medications The Food and Drug Administration (FDA) has recently issued...
FDA Warns of Rare But Serious Drug Reaction to Antiseizure Medicines Levetiracetam and Clobazam The U.S. Food and Drug Administration...
Promising Results from Roche’s Drug Phase II Trial for Lupus Nephritis Patients Lupus nephritis is a severe and potentially life-threatening...
Xeltis’ AXess Hemodialysis Vascular Conduit Trial Presents Impressive 12-Month First-in-Human Data at VEITHsymposium 2023 Medical Device News Magazine recently reported...
Medtronic, a global leader in medical technology, has recently received approval from the U.S. Food and Drug Administration (FDA) for...
Arrowhead Pharmaceuticals, a biopharmaceutical company specializing in the development of RNA interference (RNAi) therapeutics, recently shared exciting data on two...
The Food and Drug Administration (FDA) has recently approved a new medication called Defencath for the treatment of catheter-related bloodstream...
The Food and Drug Administration (FDA) has recently granted approval for a new medication called DefenCath, which is a combination...
Understanding Washout Periods and Their Significance in BioPharma Services In the field of BioPharma services, washout periods play a crucial...
Metastatic Patients Experience Improved Survival Outcomes with Precision Medicine Precision medicine, also known as personalized medicine, is revolutionizing the way...
A recent study has shown that Filterlex Medical’s CAPTIS® device is a safe and effective tool for embolic protection during...
BMW Introduces New Design Feature: Kidney Grilles within Kidney Grilles BMW, the renowned German luxury car manufacturer, has always been...
In the vast world of automobiles, there are certain models that stand out as hidden treasures, waiting to be discovered...
The Reliability of Long-Term Viable Chimeric Nephrons from Progenitor Cells as a Model for Cisplatin-Induced Toxicity – A Study in...
The Reliability of Long-term Viable Chimeric Nephrons from Progenitor Cells as a Model for Cisplatin-Induced Toxicity – Insights from Communications...
